Project in Malaysia discontinued in 2014: Douai Court of Appeals rules in favour of METabolic EXplorer

METabolic EXplorer ensures future sales of its subsidiary METEX NØØVISTA through a strategic partnership with DSM for the marketing of 1,3 propanediol (PDO) to the cosmetic ingredients market.
3 December 2019
Financial results, fourth-quarter 2019
11 February 2020
Show all

Project in Malaysia discontinued in 2014: Douai Court of Appeals rules in favour of METabolic EXplorer

Download the press release


Clermont-Ferrand, 24 January 2020 (FR0004177046 METEX), METabolic EXplorer (METEX), a cleantech biochemical company that develops and industrialises competitive and sustainable fermentation processes offering alternatives to petrochemistry for the production and marketing of functional ingredients, today reports about the dispute related to the discontinuation of its project in Malaysia in 2014.


On 23 January 2020, the Douai Court of Appeals overturned a 2017 ruling of the Lille commercial court requiring METabolic EXplorer to pay €2,820,000 in damages and interest to the plaintiffs in the lawsuit. (See Note 12 on page 22 of the annex of the half-year consolidated financial statements or page 37 of the 2019 half-year financial report.) The Court also dismissed the plaintiffs of all their other claims.

– END-

About METabolic EXplorer –

Using renewable raw materials, the company develops and industrialises innovative and competitive industrial fermentation processes as alternative to petrochemical processes to meet consumers’ new societal expectations and the objectives of the energy transition. Its functional ingredients of natural origin are used in the formulation of cosmetic products, nutrition-animal health or as intermediates for the synthesis of biomaterials.

The construction of its first production unit, through its subsidiary METEX NØØVISTA, will bring 1.3 propanediol (PDO) and butyric acid (BA) on the market.

Based at the Clermont Limagne technology park, near Clermont-Ferrand, METabolic EXplorer is listed on Euronext in Paris (Compartment C, METEX) and is included in the CAC Small Index.


Get free financial information on METabolic EXplorer by registering with:

Investor relations – ACTIFIN –
Benjamin LEHARI

Tél : + 33 (0) 1 56 88 11 11
mail :

Media relations – ACTIFIN –
Isabelle DRAY

Tél : + 33 (0) 1 56 88 11 11
mail :